Plain-English translation of NCT06846996 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a real-world study of trastuzumab deruxtecan, a targeted cancer medication designed to treat advanced stomach cancer. Researchers will follow patients who have already decided to take this medication as part of their regular medical care and will track how well it works and what side effects people experience. Unlike a typical research study, participants don't receive the drug from the study itself—instead, researchers collect information about their treatment as it happens in regular hospitals and clinics.
While this medication has shown promise in controlled clinical trials, doctors want to understand how it actually performs when used by real patients in everyday medical settings, where people may have other health conditions or take other medications that could affect results.
You likely qualify if…
You likely don't qualify if…
You will continue receiving your cancer medication through your regular doctor or hospital—the study doesn't provide the drug or ask you to change your treatment plan. Instead, researchers will collect information about your treatment and health from your medical records at regular intervals to track how long you go without the cancer worsening and to monitor any side effects you experience. The study will follow you for as long as you are taking this medication.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
China